GSK plc

NYSE:GSK

Drug Manufacturers - General

Healthcare
$48.58 -2.56%

-$1.34 today

Market cap
$97.53B
Beta
0.29
P/E (TTM)
13.3
EPS (TTM)
$1.45
Dividend yield
3.48%
52W Low $35.45High $61.70

Volume 2.02M

Average 4.07M

GSK Income Tax Expense

Income taxes recognized for the period, including current and deferred tax.

GSK plcNYSE: GSK

Income Tax Expense · Q2 FY2026 · quarter ended Jun 2026

Income tax expense turns negative

Q2 FY2026 income tax expense was -£199M, compared with £241M a year earlier. Trailing-twelve-month income tax expense was £641M. Over 3 fiscal years it compounded at +16.3% a year.

Context

  • Income tax expense amounted to 3.4% of revenue in FY2025, up 1.7 pp from a year earlier.
  • Income tax expense increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly income tax expense holds near -£199M or moves back toward the trailing-twelve-month quarterly average of £160.25M.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterJun 2026
-£199M-165.2% QoQ
Last fiscal yearDec 2025
£1.11B+111.4% YoY
LTMJun 2026
£641M+0.5% YoY
Income Tax Expense past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-182.6%——
1 year+111.4%——
3-year CAGR+16.3%——
5-year CAGR——
10-year CAGR——

Income Tax Expense history

GBP · from the income statement

Latest · FY2025
1.11B GBP
Year-over-year change
+111.4%
4-year CAGR
+91.3%

Income Tax Expense vs competitors

How GSK compares with its peers on the latest reported figures

  • Peers report in different currencies, so income tax expense is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +0.5% is the 8th highest of 10, against a peer median of +10.8%.
  • Income tax expense amounts to 1.9% of revenue for GSK, versus a peer median of 4.0%.
GSK Competitors
Income Tax Expense for GSK and competitors
Company Period LTM YoY 3-year CAGR% of revenue
NVONovo Nordisk A/SLTM Jun 2026DKK 32.31B DKK+8.7%+27.6%9.8%
LLYEli Lilly and CompanyLTM Jun 2026$6.88B USD+125.0%+108.5%8.6%
MRKMerck & Co., Inc.LTM Jun 2026$2.78B USD+1.3%+13.5%4.2%
NVSNovartis AGLTM Jun 2026$2.78B USD+40.9%+28.6%5.0%
AZNAstraZeneca PLCLTM Sep 2026$2.25B USD+10.8%—3.6%
JNJJohnson & JohnsonLTM Sep 2026$1.64B USD-74.3%+24.6%1.7%
AMGNAmgen Inc.LTM Jun 2026$1.54B USD+91.8%+16.8%4.0%
SNYSanofiLTM Jun 2026€1.2B EUR-17.1%-18.2%2.5%
GSKGSK plcLTM Jun 2026£641M GBP+0.5%+16.3%1.9%
PFEPfizer Inc.LTM Jun 2026-$164M USD+29.9%—0.3%
Peer median (excluding GSK) —+10.8%+24.6%4.0%

Competitors are the stored peer set for GSK. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

GBP
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue24.7B29.32B30.33B31.38B32.67B
Cost of Revenue8.16B9.55B8.57B9.05B9.02B
Gross Profit16.53B19.77B21.76B22.33B23.65B
Gross Margin66.9%67.4%71.8%71.2%72.4%
Research & Development5.02B5.49B6.22B6.4B7.53B
Selling, General & Admin7.07B8.37B9.39B11.02B9.09B
Operating Expenses12.18B13.34B15.02B18.31B15.31B
Depreciation & Amortization2.12B2.15B2.29B2.55B2.31B
EBITDA6.49B8.6B9.08B6.67B10.4B
EBITDA Margin26.3%29.3%29.9%21.3%31.8%
Operating Income4.36B6.43B6.75B4.02B8.34B
Operating Margin17.6%21.9%22.2%12.8%25.5%
Interest Income28M64.27M40M67.39M56M
Interest Expense784M855.53M775M657.58M687M
Other Income / Expenses(758M)(805M)(681M)(544M)(937M)
Income Before Tax3.6B5.63B6.06B3.48B7.4B
Pre-Tax Margin14.6%19.2%20.0%11.1%22.7%
Income Tax Expense83M707M756M526M1.11B
Net Income4.39B14.96B4.93B2.58B5.72B
Net Margin17.8%51.0%16.2%8.2%17.5%
EPS (Basic)2.747.442.441.262.82
EPS (Diluted)2.707.322.401.242.78
Weighted Avg Shares1.6B2.01B2.03B2.04B2.03B
Weighted Avg Shares (Diluted)1.62B2.04B2.06B2.07B2.06B

GSK plc

NYSE:GSK

Intrinsic Alpha fair value

Locked

Current Price

$48.58

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.